Qilu Pharmaceutical Co., Ltd., commonly known as Qilu Pharma, is a prominent player in the global pharmaceutical industry, headquartered in Jinan, Shandong Province, China. Founded in 1992, the company has established a strong presence in various operational regions, including Asia, Europe, and North America. Specialising in the research, development, and manufacturing of innovative medicines, Qilu Pharma focuses on areas such as oncology, cardiovascular diseases, and central nervous system disorders. Its commitment to quality and innovation has led to the successful launch of several core products, including generic and proprietary drugs that stand out for their efficacy and safety. With a robust market position, Qilu Pharmaceutical has achieved notable milestones, including numerous international certifications and partnerships, solidifying its reputation as a trusted provider in the pharmaceutical landscape.
How does Qilu Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Qilu Pharmaceutical's score of 15 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Qilu Pharmaceutical, headquartered in China (CN), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate commitments, often aligning with global initiatives to reduce greenhouse gas emissions. As the industry evolves, Qilu Pharmaceutical may adopt similar strategies to enhance its environmental responsibility and address climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Qilu Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.